Recent Publications

• 1. Abro B
  2. Maurer MJ
  3. Habermann TM
  4. Burack R
  5. Chapman JR
  6. Cohen JB
  7. Friedberg JW
  8. Inghirami GG
  9. Kahl BS
  10. Larson MC
  11. Link BL
  12. Lossos IS
  13. Martin P
  14. McDonnell T
  15. Nastoupil LJ
  16. Riska S
  17. Syrbu SI
  18. Vega F
  19. Vij K
  20. Flowers CR
  21. Cerhan JR
  22. Jaye DL
  23. Feldman AL
  Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO Cohort Study analysis.; Blood. 2024 Sep 10.
• 1. George GV
  2. Aldowitz DG
  3. Jajosky AN
  4. Wallace DS
  5. Burack WR
  6. Friedberg JW
  7. El Hussein S
  Clonally unrelated primary large B-cell lymphomas separated by over a decade involving the central nervous system and testicle: Possible predisposition to lymphomas of immune-privileged sites?; EJHaem; Vol 5(3), pp. 599-602. 2024 Apr 24.
• 1. Yeo YY
  2. Qiu H
  3. Bai Y
  4. Zhu B
  5. Chang Y
  6. Yeung J
  7. Michel HA
  8. Wright K
  9. Shaban M
  10. Sadigh S
  11. Nkosi D
  12. Shanmugam V
  13. Rock P
  14. Tung Yiu SP
  15. Cramer P
  16. Paczkowska J
  17. Stephan P
  18. Liao G
  19. Huang AY
  20. Wang H
  21. Chen H
  22. Frauenfeld L
  23. Mitra B
  24. Gewurz BE
  25. Schürch CM
  26. Zhao B
  27. Nolan GP
  28. Zhang B
  29. Shalek AK
  30. Angelo M
  31. Mahmood F
  32. Ma Q
  33. Burack WR
  34. Shipp MA
  35. Rodig SJ
  36. Jiang S
  Epstein-Barr Virus Orchestrates Spatial Reorganization and Immunomodulation within the Classic Hodgkin Lymphoma Tumor Microenvironment.; bioRxiv : the preprint server for biology. 2024 Mar 07.
• 1. Zhou T
  2. Curry CV
  3. Khanlari M
  4. Shi M
  5. Cui W
  6. Peker D
  7. Chen W
  8. Wang E
  9. Gao J
  10. Shen Q
  11. Xie W
  12. Jelloul FZ
  13. King RL
  14. Yuan J
  15. Wang X
  16. Zhao C
  17. Obiorah IE
  18. Courville EL
  19. Nomura E
  20. Cherian S
  21. Xu ML
  22. Burack WR
  23. Liu HX
  24. Jabbour EJ
  25. Takahashi K
  26. Wang W
  27. Wang SA
  28. Khoury JD
  29. Medeiros LJ
  30. Hu S
  Genetics and pathologic landscape of lineage switch of acute leukemia during therapy.; Blood cancer journal; Vol 14(1), pp. 19. 2024 Jan 25.
• 1. Cerhan JR
  2. Maurer MJ
  3. Link BK
  4. Feldman AL
  5. Habermann TM
  6. Jaye DL
  7. Burack WR
  8. McDonnell TJ
  9. Vega F
  10. Chapman JR
  11. Syrbu S
  12. Vij KR
  13. Inghirami G
  14. Leonard JP
  15. Bernal-Mizrachi L
  16. Farooq U
  17. Witzig TE
  18. Weiner GJ
  19. Wang Y
  20. Alderuccio JP
  21. Slager SL
  22. Larson MC
  23. Riska SM
  24. Gysbers BJ
  25. Lunde JJ
  26. Reicks TW
  27. Ayers AA
  28. O'Leary CB
  29. Yost KJ
  30. Liu H
  31. Nowakowski GS
  32. Ruan J
  33. Chihara D
  34. Koff JL
  35. Casulo C
  36. Thompson CA
  37. Cohen JB
  38. Kahl BS
  39. Nastoupil LJ
  40. Lossos IS
  41. Friedberg JW
  42. Martin P
  43. Flowers CR
  The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes.; American journal of hematology. 2024 Jan 13.
• 1. Burack WR
  2. Lichtman MA
  The Complete Blood Count: Increasing Its Precision and Impact.; Annals of internal medicine; Vol 176(8), pp. eL230165. 2023 Aug.
• 1. Burack WR
  2. Li H
  3. Adlowitz DG
  4. Spence JM
  5. Rimsza LM
  6. Shadman M
  7. Spier C
  8. Kaminski MS
  9. Leonard JP
  10. Leblanc M
  11. Smith SM
  12. Friedberg JW
  Subclonal TP53 mutation are frequent and predict resistance to radio-immunotherapy in follicular lymphoma.; Blood advances. 2023 Jun 28.
• 1. Centor RM
  2. Burack WR
  3. Lichtman MA
  Annals On Call - The Complete Blood Count: Cleaning Up the Clutter.; Annals of internal medicine. 2023 Apr 04.
• 1. Archibald WJ
  2. Baran AM
  3. Williams AM
  4. Salloum RM
  5. Richard Burack W
  6. Evans AG
  7. Syposs CR
  8. Zent CS
  The role of splenectomy in management of splenic B-cell lymphomas.; Leukemia research; Vol 128, pp. 107053. 2023 Mar 02.
• 1. Burack WR
  2. Lichtman MA
  The Complete Blood Count: Increasing Its Precision and Impact.; Annals of internal medicine. 2023 Jan 31.
• 1. George GV
  2. Wallace DS
  3. Wang Y
  4. Carney J
  5. Elsadawi M
  6. Burack WR
  7. Evans AG
  8. Barr PM
  9. Velez MJ
  10. El Hussein S
  ALK-rearranged CD30-positive poorly differentiated lung adenocarcinoma, mimicking anaplastic large-cell lymphoma.; Histopathology. 2023 Jan 30.
• 1. Maurer MJ
  2. Casulo C
  3. Larson MC
  4. Habermann TM
  5. Lossos IS
  6. Wang Y
  7. Nastoupil LJ
  8. Strouse C
  9. Chihara D
  10. Martin P
  11. Cohen JB
  12. Kahl BS
  13. Burack WR
  14. Koff JL
  15. Mun Y
  16. Masaquel A
  17. Wu M
  18. Wei MC
  19. Shewade A
  20. Li J
  21. Cerhan JR
  22. Link BK
  23. Flowers CR
  Matching-adjusted indirect comparison from the Lymphoma Epidemiology of Outcomes Consortium for Real World Evidence (LEO CReWE) study to a clinical trial of mosunetuzumab in relapsed or refractory follicular lymphoma.; Haematologica. 2023 Jan 30.
• 1. El Hussein S
  2. Fang H
  3. Jelloul FZ
  4. Wang W
  5. Loghavi S
  6. Miranda RN
  7. Friedberg JW
  8. Burack WR
  9. Evans AG
  10. Xu J
  11. Medeiros LJ
  T-Cell-Rich Hodgkin Lymphoma With Features of Classic Hodgkin Lymphoma and Nodular Lymphocyte-Predominant Hodgkin Lymphoma: A Borderline Category With Overlapping Morphologic and Immunophenotypic Features.; Archives of pathology & laboratory medicine. 2023 Jan 07.
• 1. El Hussein S
  2. Yabe M
  3. Wang W
  4. Pemmaraju N
  5. Loghavi S
  6. Jelloul FZ
  7. Fang H
  8. Medeiros LJ
  9. Burack WR
  10. Evans AG
  11. Liesveld JL
  12. Bennett JM
  Blastic plasmacytoid dendritic cell neoplasm (BPDCN) arising in the setting of polycythemia vera (PV): An illustration of the emerging role of flow cytometry analysis in monitoring progression of myeloproliferative neoplasms.; EJHaem; Vol 3(3), pp. 954-957. 2022 Jul 03.
• 1. El Hussein S
  2. Wang X
  3. Fang H
  4. Jelloul FZ
  5. Wang W
  6. Loghavi S
  7. Vega F
  8. Miranda RN
  9. Muzzafar T
  10. Manning JT
  11. Khoury JD
  12. Burack WR
  13. Evans AG
  14. Medeiros LJ
  Nodular Lymphocyte-predominant Hodgkin Lymphoma With Nodular Sclerosis: An Underrecognized Feature Associated With Pattern D.; The American journal of surgical pathology. 2022 May 16.
• 1. Casulo C
  2. Larson MC
  3. Lunde JJ
  4. Habermann TM
  5. Lossos IS
  6. Wang Y
  7. Nastoupil LJ
  8. Strouse C
  9. Chihara D
  10. Martin P
  11. Cohen JB
  12. Kahl BS
  13. Burack WR
  14. Koff JL
  15. Mun Y
  16. Masaquel A
  17. Wu M
  18. Wei MC
  19. Shewade A
  20. Li J
  21. Cerhan J
  22. Flowers CR
  23. Link BK
  24. Maurer MJ
  Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study.; The Lancet. Haematology; Vol 9(4). 2022 Apr.
• 1. Liu L
  2. Adlowitz DG
  3. Rock P
  4. Casulo C
  5. Burack WR
  Hypergammaglobulinemia as a presenting feature of Mantle cell lymphoma.; Leukemia & lymphoma. 2022 Mar 31.
• 1. Komisarof J
  2. Lipof J
  3. DiTursi J
  4. Chowdhry A
  5. Grace Choung HY
  6. Burack WR
  7. Constine L
  8. Passero F
  An Unusual Case of Multiple Myeloma with Light-Chain Cast Nephropathy Secondary to a Very Large Plasmacytoma without Bone Marrow Involvement.; Case reports in hematology; Vol 2022. 2022.
• 1. Zengin HB
  2. Reyes-Barron C
  3. Cusick E
  4. Cordisco M
  5. Katzman PJ
  6. Burack WR
  7. Scott G
  A Young Boy With Hemophagocytic Lymphohistiocytosis Presenting With Vaccine-Related Granulomatous Dermatitis: A Case Report and Literature Review.; The American Journal of dermatopathology; Vol 43(12). 2021 Dec 01.
• 1. Chiodin G
  2. Allen JD
  3. Bryant D
  4. Rock P
  5. Martino EA
  6. Valle-Argos B
  7. Duriez PJ
  8. Watanabe Y
  9. Henderson I
  10. Blachly JS
  11. McCann KJ
  12. Strefford JC
  13. Packham G
  14. Geijtenbeek TB
  15. Figdor C
  16. Wright G
  17. Staudt LM
  18. Burack R
  19. Bowden T
  20. Crispin M
  21. Stevenson FK
  22. Forconi F
  Insertion of atypical glycans into the tumor antigen-binding site identifies DLBCLs with distinct origin and behavior.; Blood. 2021 Aug 23.
• 1. Valle-Argos B
  2. Chiodin G
  3. Bryant DJ
  4. Taylor J
  5. Lemm E
  6. Duriez PJ
  7. Rock PJ
  8. Strefford JC
  9. Forconi F
  10. Burack RW
  11. Packham G
  12. Stevenson FK
  DC-SIGN binding to mannosylated B-cell receptors in follicular lymphoma down-modulates receptor signaling capacity.; Scientific reports; Vol 11(1). 2021 Jun 03.
• 1. Palacios F
  2. Yan XJ
  3. Ferrer G
  4. Chen SS
  5. Vergani S
  6. Yang X
  7. Gardner J
  8. Barrientos JC
  9. Rock P
  10. Burack R
  11. Kolitz JE
  12. Allen SL
  13. Kharas MG
  14. Abdel-Wahab O
  15. Rai KR
  16. Chiorazzi N
  Musashi 2 influences chronic lymphocytic leukemia cell survival and growth making it a potential therapeutic target.; Leukemia; Vol 35(4). 2021 Apr.
• 1. Fries C
  2. Adlowitz DG
  3. Spence JM
  4. Spence JP
  5. Rock PJ
  6. Burack WR
  Acute lymphoblastic leukemia clonal distribution between bone marrow and peripheral blood.; Pediatric blood & cancer. 2020 Apr 11.
• 1. Meacham PJ
  2. Williams AM
  3. Strawderman M
  4. Baran AM
  5. Archibald WJ
  6. Wallace DS
  7. Tschernia NP
  8. Burack WR
  9. Barr PM
  10. Zent CS
  Additional B-cell malignancies in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL).; Leukemia & lymphoma. 2020 Mar 16.
• 1. Norris PAA
  2. Segel GB
  3. Burack WR
  4. Sachs UJ
  5. Lissenberg-Thunnissen SN
  6. Vidarsson G
  7. Bayat B
  8. Cserti-Gazdewich CM
  9. Callum J
  10. Lin Y
  11. Branch D
  12. Kapur R
  13. Semple JW
  14. Lazarus AH
  FcγRI and FcγRIII on splenic macrophages mediate phagocytosis of anti-glycoprotein IIb/IIIa autoantibody-opsonized platelets in immune thrombocytopenia.; Haematologica. 2020 Feb 27.
• 1. Hudson CA
  2. Burack WR
  3. Bennett JM
  Emerging utility of flow cytometry in the diagnosis of chronic myelomonocytic leukemia.; Leukemia research; Vol 73. 2018 Aug 28.
• 1. Hudson CA
  2. Burack WR
  3. Leary PC
  4. Bennett JM
  Clinical Utility of Classical and Nonclassical Monocyte Percentage in the Diagnosis of Chronic Myelomonocytic Leukemia.; American journal of clinical pathology. 2018 Jul 05.
• 1. Aslam R
  2. Burack WR
  3. Segel GB
  4. McVey M
  5. Spence SA
  6. Semple JW
  Intravenous immunoglobulin treatment of spleen cells from patients with immune thrombocytopenia significantly increases the percentage of myeloid-derived suppressor cells.; British journal of haematology; Vol 181(2). 2018 Apr.
• 1. Barr PM
  2. Li H
  3. Burack WR
  4. LeBlanc M
  5. Smith SM
  6. Gopal AK
  7. Floyd JD
  8. Persky DO
  9. Press OW
  10. Fisher RI
  11. Friedberg JW
  R-CHOP, radioimmunotherapy, and maintenance rituximab in untreated follicular lymphoma (SWOG S0801): a single-arm, phase 2, multicentre study.; The Lancet. Haematology; Vol 5(3). 2018 Mar.
• 1. Fries C
  2. Burack WR
  A clinical perspective on immunoglobulin heavy chain clonal heterogeneity in B cell acute lymphoblastic leukemia.; Leukemia research; Vol 75. 2018 Jan.
• 1. Patel N
  2. Hoffman CM
  3. Goldman BI
  4. Bentley K
  5. Burack WR
  6. Evans AG
  Green Inclusions in Neutrophils and Monocytes Are an Indicator of Acute Liver Injury and High Mortality.; Acta haematologica; Vol 138(2). 2017 Aug 17.
• 1. Burack WR
  2. Spence JM
  3. Spence JP
  4. Spence SA
  5. Rock PJ
  6. Shenoy GN
  7. Shultz LD
  8. Bankert RB
  9. Bernstein SH
  Patient-derived xenografts of low-grade B-cell lymphomas demonstrate roles of the tumor microenvironment.; Blood advances; Vol 1(16). 2017 Jul 11.
• 1. Reyes-Barron C
  2. Burack WR
  3. Rothberg PG
  4. Ding Y
  Next-Generation Sequencing for Minimal Residual Disease Surveillance in Acute Lymphoblastic Leukemia: An Update.; Critical reviews in oncogenesis; Vol 22(5-6). 2017.
• 1. Hunter BD
  2. Herr M
  3. Meacham PJ
  4. Barlaskar F
  5. Evans AG
  6. Burack WR
  7. Liesveld JL
  8. Becker MW
  9. Milner LA
  10. Constine LS
  11. Dhakal S
  12. Barr PM
  13. Friedberg JW
  14. Casulo C
  Late Relapses After High-dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Diffuse Large B-cell Lymphoma in the Rituximab Era.; Clinical lymphoma, myeloma & leukemia. 2016 Nov 23.
• 1. Youn P
  2. Cummings MA
  3. Dhakal S
  4. Burack WR
  5. Casulo C
  6. Barr PM
  7. Friedberg JW
  8. Constine LS
  Prognostic Impact of Cell of Origin in Limited-Stage Diffuse Large B-Cell Lymphoma Treated With R-CHOP With or Without Radiation Therapy.; International journal of radiation oncology, biology, physics; Vol 96(2S). 2016 Oct 1.
• 1. Redd L
  2. Schmelz M
  3. Burack WR
  4. Cook JR
  5. Day AW
  6. Rimsza L
  Langerhans Cell Histiocytosis Shows Distinct Cytoplasmic Expression of Major Histocompatibility Class II Antigens.; Journal of hematopathology; Vol 9(3). 2016 Sep.
• 1. Evans AG
  2. Ahmad A
  3. Burack WR
  4. Iqbal MA
  Combined comparative genomic hybridization and single-nucleotide polymorphism array detects cryptic chromosomal lesions in both myelodysplastic syndromes and cytopenias of undetermined significance.; Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2016 Jul 8.
• 1. Kuzin II
  2. Kates SL
  3. Ju Y
  4. Zhang L
  5. Rahimi H
  6. Wojciechowski W
  7. Bernstein SH
  8. Burack R
  9. Schwarz EM
  10. Bottaro A
  Increased numbers of CD23(+) CD21(hi) Bin-like B cells in human reactive and rheumatoid arthritis lymph nodes.; European journal of immunology. 2016 Apr 23.
• 1. Aslam R
  2. Segel GB
  3. Burack R
  4. Spence SA
  5. Speck ER
  6. Guo L
  7. Semple JW
  Splenic lymphocyte subtypes in immune thrombocytopenia: increased presence of a subtype of B-regulatory cells.; British journal of haematology; Vol 173(1). 2016 Apr.
• 1. Lindorfer MA
  2. Cook EM
  3. Tupitza JC
  4. Zent CS
  5. Burack R
  6. de Jong RN
  7. Beurskens FJ
  8. Schuurman J
  9. Parren PW
  10. Taylor RP
  Real-time analysis of the detailed sequence of cellular events in mAb-mediated complement-dependent cytotoxicity of B-cell lines and of chronic lymphocytic leukemia B-cells.; Molecular immunology; Vol 70. 2016 Feb.
• 1. Nedelkovska H
  2. Rosenberg AF
  3. Hilchey SP
  4. Hyrien O
  5. Burack WR
  6. Quataert SA
  7. Baker CM
  8. Azadniv M
  9. Welle SL
  10. Ansell SM
  11. Kim M
  12. Bernstein SH
  Follicular Lymphoma Tregs Have a Distinct Transcription Profile Impacting Their Migration and Retention in the Malignant Lymph Node.; PloS one; Vol 11(5). 2016.
• 1. Till BG
  2. Li H
  3. Bernstein SH
  4. Fisher RI
  5. Burack WR
  6. Rimsza LM
  7. Floyd JD
  8. DaSilva MA
  9. Moore DF
  10. Pozdnyakova O
  11. Smith SM
  12. LeBlanc M
  13. Friedberg JW
  Phase II trial of R-CHOP plus bortezomib induction therapy followed by bortezomib maintenance for newly diagnosed mantle cell lymphoma: SWOG S0601.; British journal of haematology; Vol 172(2). 2016 Jan.
• 1. Halliley JL
  2. Tipton CM
  3. Liesveld J
  4. Rosenberg AF
  5. Darce J
  6. Gregoretti IV
  7. Popova L
  8. Kaminiski D
  9. Fucile CF
  10. Albizua I
  11. Kyu S
  12. Chiang KY
  13. Bradley KT
  14. Burack R
  15. Slifka M
  16. Hammarlund E
  17. Wu H
  18. Zhao L
  19. Walsh EE
  20. Falsey AR
  21. Randall TD
  22. Cheung WC
  23. Sanz I
  24. Lee FE
  Long-Lived Plasma Cells Are Contained within the CD19(-)CD38(hi)CD138(+) Subset in Human Bone Marrow.; Immunity; Vol 43(1). 2015 Jul 21.
• 1. Pulvino M
  2. Chen L
  3. Oleksyn D
  4. Li J
  5. Compitello G
  6. Rossi R
  7. Spence S
  8. Balakrishnan V
  9. Jordan C
  10. Poligone B
  11. Casulo C
  12. Burack R
  13. Shapiro JL
  14. Bernstein S
  15. Friedberg JW
  16. Deshaies RJ
  17. Land H
  18. Zhao J
  Inhibition of COP9-signalosome (CSN) deneddylating activity and tumor growth of diffuse large B-cell lymphomas by doxycycline.; Oncotarget; Vol 6(17). 2015 Jun 20.
• 1. Evans AG
  2. Rothberg PG
  3. Burack WR
  4. Huntington SF
  5. Porter DL
  6. Friedberg JW
  7. Liesveld JL
  Evolution to plasmablastic lymphoma evades CD19-directed chimeric antigen receptor T cells.; British journal of haematology. 2015 Jun 18.
• 1. Vajpayee N
  2. Burack R
  3. Wang D
  4. Hutchison RE
  5. Gajra A
  Immunohistochemical expression of mTOR in germinal center and nongerminal center group of diffuse large B-cell lymphoma: a clinicopathological study.; Clinical lymphoma, myeloma & leukemia; Vol 15(3). 2015 Mar.
• 1. Frederiksen JK
  2. Sharma M
  3. Casulo C
  4. Burack WR
  Systematic review of the effectiveness of fine-needle aspiration and/or core needle biopsy for subclassifying lymphoma.; Archives of pathology & laboratory medicine; Vol 139(2). 2015 Feb.
• 1. Casulo C
  2. Burack WR
  3. Friedberg JW
  Transformed follicular non-Hodgkin lymphoma.; Blood; Vol 125(1). 2015 Jan 1.
• 1. Spence JM
  2. Spence JP
  3. Abumoussa A
  4. Burack WR
  Ultradeep analysis of tumor heterogeneity in regions of somatic hypermutation.; Genome medicine; Vol 7(1). 2015.
• 1. Zent CS
  2. Burack WR
  Mutations in chronic lymphocytic leukemia and how they affect therapy choice: focus on NOTCH1, SF3B1, and TP53.; Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program; Vol 2014(1). 2014 Dec 5.